Evogene

Evogene Liabilities

The The Liabilities of Evogene (EVGN) as of Oct 12, 2026 is 8.07 M USD. In the previous year, The Liabilities was 25.03 M USD — a change of -67.75% (lower).

Liabilities

8.07 MUSD

YoY

-67.75%

Last updated:

In 2025, Evogene's total liabilities amounted to 8.07 M USD, a -67.75% difference from the 25.03 M USD total liabilities in the previous year.

The Evogene Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
8.39 M USD
Jan 1, 2019
11.15 M USD
Jan 1, 2020
15.03 M USD
Jan 1, 2021
12.88 M USD
Jan 1, 2022
21.34 M USD
Jan 1, 2023
22.42 M USD
Jan 1, 2024
25.03 M USD
Jan 1, 2025
8.07 M USD
The Evogene Liabilities history
YEARLiabilitiesYoY
8.07 MUSD-67.75%
25.03 MUSD+11.64%
22.42 MUSD+5.06%
21.34 MUSD+65.60%
12.88 MUSD-14.30%
15.03 MUSD+34.86%
11.15 MUSD+32.89%
8.39 MUSD+1.99%
8.22 MUSD-5.44%
8.70 MUSD-1.65%
8.84 MUSD-23.13%
11.50 MUSD—
Access this data via the Eulerpool API

Evogene Stock analysis

What does Evogene do? Evogene Ltd is an Israeli biotechnology company that focuses on the application of computational biology and genomics to agriculture and biology. The company originated from a spin-off of the Weizmann Institute of Science and was founded in 2002. Today, it is a leading global provider of biotechnology solutions for the agriculture and biotechnology industry. Evogene's business model is based on providing innovative technologies and services for its customers, aiming to improve plant development, particularly in terms of resistance to environmental stress factors and pests. To achieve this, the company utilizes modern biotechnology methods and leverages artificial intelligence. It employs advanced machine learning and large-scale data analysis techniques to gain a better understanding of underlying biological processes. Evogene operates in three core areas: agricultural biotechnology, drug discovery biotechnology, and biomaterials. The company is capable of offering customized biological solutions tailored to the specific needs of its customers. Agricultural biotechnology is one of Evogene's key sectors. It utilizes state-of-the-art technologies and methods to generate plant resistance to pests and environmental factors. With the help of a reliable pipeline of innovative products such as seeds, biostimulants, and fertilizers, Evogene aims to play an important role in food security, environmental sustainability, and resilience to climate change. The company has a strong product pipeline aimed at improving nutrient efficiency of crops while reducing environmental impact from pesticide and fertilizer use. One such product resulting from this pipeline is EvoCanna, which utilizes modern genomics methods to optimize hemp plants in terms of phytocannabinoid biosynthesis. The goal of Evogene's drug discovery biotechnology and biomaterials sector is to develop innovative and effective medicines for diseases such as cancer and obesity. The company utilizes modern machine learning and large-scale data analysis methods to identify the potential of new drug candidates. In the biomaterials sector, Evogene aims to develop innovative technologies and solutions for better and more sustainable use of natural resources. An important application of this concept is biostimulants, which can improve the growth rate, stress tolerance, and yield of crops. Additionally, the company can offer new materials and environmentally friendly solutions in the packaging industry. Overall, Evogene has achieved impressive success in recent years and established itself as a leading biotechnology company. By utilizing cutting-edge technologies, methods, and scientific concepts, particularly artificial intelligence and machine learning, and by operating as a responsible company in the fields of agriculture, biomaterials, and programming, Evogene is able to offer innovative biotechnological solutions. The company is currently well-equipped and has a promising pipeline of groundbreaking innovation projects that embody the desire for a sustainable worldview. Evogene is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Evogene's Liabilities

Evogene's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Evogene's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Evogene's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Evogene's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Evogene’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Evogene stock

The Liabilities of Evogene is 8.07 M USD in 2025.

The Liabilities of Evogene changed from 25.03 M USD to 8.07 M USD, representing a -67.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Evogene since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Evogene historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Evogene

All Key Metrics — Evogene